日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/11/06 | 8,060 | 8,090 | 7,930 | 7,950 | -20 | -0.3% | 216,300 |
| 2017/11/02 | 8,010 | 8,020 | 7,950 | 7,970 | -40 | -0.5% | 163,800 |
| 2017/11/01 | 8,030 | 8,060 | 7,970 | 8,010 | -10 | -0.1% | 299,600 |
| 2017/10/31 | 7,960 | 8,030 | 7,930 | 8,020 | +30 | +0.4% | 207,300 |
| 2017/10/30 | 8,030 | 8,080 | 7,930 | 7,990 | -130 | -1.6% | 563,000 |
| 2017/10/27 | 8,100 | 8,140 | 8,050 | 8,120 | +60 | +0.7% | 182,400 |
| 2017/10/26 | 8,130 | 8,150 | 8,050 | 8,060 | -40 | -0.5% | 185,200 |
| 2017/10/25 | 8,150 | 8,190 | 8,080 | 8,100 | -90 | -1.1% | 202,700 |
| 2017/10/24 | 8,100 | 8,200 | 8,060 | 8,190 | -10 | -0.1% | 276,500 |
| 2017/10/23 | 8,010 | 8,210 | 7,970 | 8,200 | +310 | +3.9% | 377,200 |
| 2017/10/20 | 7,780 | 7,920 | 7,770 | 7,890 | +150 | +1.9% | 315,900 |
| 2017/10/19 | 7,740 | 7,800 | 7,650 | 7,740 | ±0 | ±0% | 547,500 |
| 2017/10/18 | 7,770 | 7,770 | 7,670 | 7,740 | +10 | +0.1% | 268,300 |
| 2017/10/17 | 7,820 | 7,840 | 7,710 | 7,730 | -110 | -1.4% | 175,100 |
| 2017/10/16 | 7,910 | 7,940 | 7,800 | 7,840 | -90 | -1.1% | 189,200 |
| 2017/10/13 | 7,850 | 7,960 | 7,830 | 7,930 | +10 | +0.1% | 176,600 |
| 2017/10/12 | 7,890 | 8,020 | 7,850 | 7,920 | +70 | +0.9% | 168,500 |
| 2017/10/11 | 7,870 | 7,900 | 7,810 | 7,850 | +10 | +0.1% | 120,100 |
| 2017/10/10 | 7,800 | 7,880 | 7,770 | 7,840 | +90 | +1.2% | 199,900 |
| 2017/10/06 | 7,710 | 7,770 | 7,680 | 7,750 | +50 | +0.6% | 112,600 |
| 2017/10/05 | 7,730 | 7,730 | 7,670 | 7,700 | -100 | -1.3% | 126,700 |
| 2017/10/04 | 7,730 | 7,820 | 7,710 | 7,800 | +50 | +0.6% | 230,200 |
| 2017/10/03 | 7,740 | 7,760 | 7,690 | 7,750 | +40 | +0.5% | 170,100 |
| 2017/10/02 | 7,840 | 7,860 | 7,660 | 7,710 | -100 | -1.3% | 147,000 |
| 2017/09/29 | 7,740 | 7,810 | 7,730 | 7,810 | +60 | +0.8% | 129,000 |
| 2017/09/28 | 7,720 | 7,760 | 7,630 | 7,750 | +90 | +1.2% | 132,500 |
| 2017/09/27 | 7,670 | 7,680 | 7,550 | 7,660 | -60 | -0.8% | 112,200 |
| 2017/09/26 | 7,680 | 7,740 | 7,620 | 7,720 | +70 | +0.9% | 129,400 |
| 2017/09/25 | 7,660 | 7,670 | 7,580 | 7,650 | +30 | +0.4% | 178,900 |
| 2017/09/22 | 7,700 | 7,730 | 7,590 | 7,620 | -80 | -1% | 230,000 |
| 2017/09/21 | 7,820 | 7,840 | 7,640 | 7,700 | -70 | -0.9% | 297,600 |
| 2017/09/20 | 7,910 | 7,930 | 7,750 | 7,770 | -180 | -2.3% | 188,500 |
| 2017/09/19 | 7,900 | 7,960 | 7,760 | 7,950 | +30 | +0.4% | 225,600 |
| 2017/09/15 | 7,800 | 7,940 | 7,760 | 7,920 | +100 | +1.3% | 216,700 |
| 2017/09/14 | 7,770 | 7,890 | 7,750 | 7,820 | +40 | +0.5% | 262,400 |
| 2017/09/13 | 7,760 | 7,820 | 7,710 | 7,780 | -20 | -0.3% | 161,800 |
| 2017/09/12 | 7,800 | 7,820 | 7,730 | 7,800 | +30 | +0.4% | 190,800 |
| 2017/09/11 | 7,590 | 7,780 | 7,560 | 7,770 | +290 | +3.9% | 179,800 |
| 2017/09/08 | 7,460 | 7,530 | 7,450 | 7,480 | +60 | +0.8% | 155,800 |
| 2017/09/07 | 7,320 | 7,470 | 7,320 | 7,420 | ±0 | ±0% | 215,800 |
| 2017/09/06 | 7,330 | 7,480 | 7,300 | 7,420 | +50 | +0.7% | 125,400 |
| 2017/09/05 | 7,480 | 7,480 | 7,310 | 7,370 | -140 | -1.9% | 170,100 |
| 2017/09/04 | 7,610 | 7,630 | 7,490 | 7,510 | -120 | -1.6% | 108,200 |
| 2017/09/01 | 7,700 | 7,700 | 7,590 | 7,630 | -20 | -0.3% | 122,400 |
| 2017/08/31 | 7,640 | 7,670 | 7,560 | 7,650 | +20 | +0.3% | 104,900 |
| 2017/08/30 | 7,500 | 7,630 | 7,500 | 7,630 | +170 | +2.3% | 194,700 |
| 2017/08/29 | 7,380 | 7,480 | 7,320 | 7,460 | +60 | +0.8% | 122,300 |
| 2017/08/28 | 7,210 | 7,410 | 7,210 | 7,400 | +260 | +3.6% | 152,300 |
| 2017/08/25 | 7,150 | 7,170 | 7,060 | 7,140 | -20 | -0.3% | 118,500 |
| 2017/08/24 | 7,200 | 7,240 | 7,140 | 7,160 | -60 | -0.8% | 99,800 |
1851～
1900
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
